Why the study?
Does NG-nitro-L-arginine enhance norepinephrine- and angiotensin II-induced renal vasoconstriction and antidiuresis in anesthetized dogs?
Does NG-nitro-L-arginine enhance norepinephrine- and angiotensin II-induced renal vasoconstriction and antidiuresis in anesthetized dogs?
Endogenous nitric oxide likely functions as an inhibitory modulator in norepinephrine- or angiotensin II-induced renal vasoconstriction and antidiuresis.
Answers are grounded in this paper and cite their sources.
Endogenous NO modulates renal vasoconstriction by NE and Ang II in dogs; leaves open translation to human physiology or therapy.
We investigated whether endogenous nitric oxide (NO) has a role as an inhibitory modulator of norepinephrine (NE)- and angiotensin II (Ang II)-induced renal effects in anesthetized dogs. Intrarenal arterial infusion of NE (100 ng/kg/min) or Ang II (10 ng/kg/min) decreased renal blood flow (RBF), glomerular filtration rate (GFR) and urine formation. The NE- or Ang II-induced renal effects were augmented by the intrarenal administration of a NO synthase inhibitor, NG-nitro-L-arginine (NOARG), at doses (10 and 40 micrograms/kg/min) which did not affect the mean arterial blood pressure and heart rate. The stimulating activity of NOARG on NE- or Ang II-induced renal effects were abolished by the simultaneous administration of L-arginine, a NO precursor. These findings suggest that endogenous NO, which is probably generated within the kidney, functions as an inhibitory modulator in NE- or Ang II-induced renal vasoconstriction and antidiuresis.
No takes yet. Share an insight, caveat, or question.
Matsumura et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: